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ABSTRACT    
AIM: To devise and prioritize new ways of accelerating progress in reducing the risks 
and consequences of stroke. 
METHODS: Preliminary work was performed by 7 working groups of stroke leaders, 
followed by a Synergium (a forum for working synergistically together) with about 100 
additional participants. The resulting draft document had further input from contributors 
outside the Synergium. 
RESULTS: Recommendations:  
Basic Science, Drug Development and Technology: There is a need to develop: 1) New 
systems of working together to break down the prevalent “silo” mentality; 2) New 
models of vertically integrated basic, clinical and epidemiological disciplines; and 3) 
Efficient methods of identifying other relevant areas of science. 
Stroke Prevention: 1) Establish a global chronic disease prevention initiative with stroke 
as a major focus. 2) Recognize not only abrupt clinical stroke, but subtle subclinical 
stroke, the commonest type of cerebrovascular disease, leading to impairments of 
executive function. 3) Develop, implement and evaluate a population approach for 
stroke prevention. 4) Develop public health communication strategies using traditional 
and novel (e.g., social media/marketing) techniques. 
Acute Stroke Management: Continue the establishment of stroke centers, stroke units, 
regional systems of emergency stroke care and telestroke networks. 
Brain Recovery and Rehabilitation:  1) Translate best neuroscience, including animal 
and human studies, into post-stroke recovery research and clinical care.  2) Standardize 
post-stroke rehabilitation based on best evidence. 3) Develop consensus on, then 
implementation of, standardized clinical and surrogate assessments. 4) Carry out 
rigorous clinical research to advance stroke recovery. 
Into the 21st Century: Web, technology and communications: 1) Work towards global 
unrestricted access to stroke-related information.  2) Build centralized electronic 
archives and registries.  
Foster Cooperation among Stakeholders (large stroke organizations, nongovernmental 
organizations, governments, patient organizations and industry) to enhance stroke care. 
Educate and energize professionals, patients, the public and policy makers by using a 
‘Brain Health’ concept that enables promotion of preventive measures.  
CONCLUSIONS: To accelerate progress in stroke we must reach beyond the current 
status, scientifically, conceptually and pragmatically. Advances can be made not only by 
doing, but ceasing to do.  Many savings in time, money and effort could result from 
stopping practices driven by unsubstantiated opinion, unproven approaches and 
financial gain.  Systematic integration of knowledge into programs coupled with careful 
evaluation can speed the pace of progress. 
STROKE: WORKING TOWARDS A PRIORITIZED WORLD AGENDA 
     Birthdays invite reflection and planning. The journal STROKE has turned 40, 
providing not only an occasion to celebrate the past, but also an opportunity to help 
shape the future. Most of the leaders in stroke have been involved with the journal as 
authors, reviewers or editors, providing an umbrella for collaboration. The participants of 
this Synergium are leaders in the field and although the event was supported by major 
stroke organizations worldwide; it was a gathering of individuals interested in finding 
common solutions. 
     A result has been a Synergium, a word coined by the first author to describe a forum 
for working synergistically together. Seven working groups suggested three main 
recommendations for progress that were refined during a one day face to face meeting. 
In addition about 100 other participants and contributors from outside the Synergium 
provided input to the final document. 
The Past 40 Years 
     More progress has been made in stroke over the past four decades than in the 
previous four millennia.  In 1970, a landmark paper showed that hypertension was a 
strong risk factor for all types of stroke.1 Thereafter, other major risk factors for stroke 
were identified. Subsequent studies showed that many can be reduced and that their 
control decreases the incidence of stroke.  The late 1970’s saw the first proof that 
aspirin prevents stroke.2 This was followed by the introduction of other efficacious 
antiplatelet agents.  The first modern comprehensive stroke unit was inaugurated in 
1975,3 and tPA’s effectiveness in acute stroke was demonstrated in 1995.4   Carotid 
endarterectomy was shown to prevent stroke in selected patients and angioplasty and 
stenting are currently being tested for similar purposes.  Coiling offers an alternative to 
brain aneurysm and arteriovenous malformation surgery.  Brain imaging has 
revolutionalized the diagnosis of stroke and the management of stroke patients.  Steady 
progress enhances our understanding of the mechanisms of brain injury, repair, 
plasticity and recovery.  Each of the previous Editors-in-Chief of STROKE (Clark 
Millikan, Fletcher McDowell, Henry Barnett, Oscar Reinmuth and Mark Dyken), 
summarized the main developments and issues in the field during their tenures, 
covering the years 1970 to 2000.5-9 The developments in subsequent years have been 
documented in the annual Advances feature of STROKE. 
Paradoxes of progress 
     Progress breeds paradoxes. Stroke is preventable yet is increasing globally. The 
same few major risk factors account for much of the leading health problems of the 
world, but remain uncontrolled in the majority of affected individuals. Management of 
risk factors is the most readily applicable and affordable part of our knowledge, but 
prevention is neglected, and most environments are inhospitable to healthy living. 
     While many advances in the understanding of excitotoxicity, neurotransmitter 
depletion, oxidative stress, mitochondrial failure, inflammation and apoptosis have 
occurred, this has been accomplished in relative isolation from the knowledge gained on 
the same mechanisms which underlie other major afflictions of the brain such as 
Alzheimer disease, Parkinson’s disease, epilepsy, multiple sclerosis and brain trauma. 
          Although the symptoms of stroke are well described, the majority at risk do not 
recognize their significance.  In one study, only 1 in 6 individuals were aware that a 
treatment for stroke exists, and that at the time of the study, it had to be given no more 
than 3 hours after symptom onset.10  In stroke we know that time is brain, but too few 
brains arrive in time.  While we have learned to treat transient ischemic attack as an 
emergency, only about 1 in 8 of first time stroke patients have a prior TIA.11  We must  
find other ways of identifying those at high risk for stroke. Sub-clinical (“silent”) strokes 
are the most common type of stroke, executive function impairment being its earliest 
manifestation, but this fact is barely recognized and cognition seldom measured12. 
     Stroke unit care improves outcomes of patients of all ages, stroke types and 
severities, but remains the exception rather than the rule in stroke care. The 
understanding of the neurobiology of brain injury, repair and plasticity has advanced, 
but no histoprotective or reparative drug has yet proved efficacious. 
     Stroke rehabilitation works, but is largely unavailable for the time and intensity 
required. Effective drugs are neither accessible nor affordable in many developing 
countries, nor used optimally in developed ones. Unproven, costly, or misdirected 
practices continue to drain resources and prevent the pursuit of more cost effective 
approaches.   
     Although the challenges are daunting, the achievements of the past four decades 
are inspiring, having witnessed the transformation of stroke from an area notable for 
diagnostic precision and therapeutic impotence to a field ripe for further advances in 
prevention, acute treatment, and rehabilitation. 
GROUPS’ RECOMMENDATIONS  
I. Basic science, drug development and technology 
Step 1.  Address Unmet Needs 
     In all aspects of basic science, drug development and technology, there is clearly a 
need to “do things differently” if there is to be a major advance in the development of 
new interventions.13, 14 Over the last few years, there has been a dearth of advances 
which have limited genuine leaps in the understanding of the basic science and 
pathogenesis of stroke, and hence new targets for therapy.15, 16 To counter this, a 
radical approach is suggested in the following areas: 
Recommendations: 
1. Establish a new taxonomy of disease.  This could be based on the genetics or 
another taxonomy that makes scientists and clinical investigators think about the 
disease process in a completely different way.  The natural consequence of this would 
be the development of personalized medicine.17 A simple example might be the genetic 
basis of vascular collateralization. 
 
2. Learn from other scientific disciplines and diseases. It is time to step into other 
domains so that knowledge in other areas may be readily applied to the problem of 
stroke.  In other words, we need to scan the scientific landscape to embrace new ideas 
and approaches. 
3. Challenge existing models of disease and embrace even more basic models to 
have a more “blue sky approach” to science.  Studies in Drosophila, worms, and zebra 
fish, among others, might generate novel new ideas about the stroke process.18-20   Yet, 
at the same time, pursue more clinical models with human cells, tissue and samples. 
For example, sampling in patients undergoing carotid endarterectomy or in patients 
subjected to transient cerebral ischemia during neurosurgical procedures.  
 
Step 2: Implement three approaches that will accelerate the capacity to address 
unmet needs 
There are processes that could be put in place which may result in needs being met 
earlier rather than later. 
Recommendations: 
1. Develop new systems of collaboration to break down the silo mentality currently 
rife in the stroke community.  This could involve the gathering together of basic and 
clinical scientists from a variety of disciplines and putting them to work to solve major 
stroke problems.  Alternatively, it could involve adding one or two “odd ball” players to 
existing teams to encourage them to think outside the box.  For example, drosophila 
models have been used for Parkinson’s disease. HIF-1a responses are conserved from 
flies to mammals. Can we build on these fundamentals for stroke? In horseshoe crabs 
(living fossils), coagulation and immune systems are merged. Can we leverage this type 
of evolutionary biology to dissect and target the links between inflammation and 
thrombosis in stroke? Evolutionary biology also indicates that neurogenesis and 
angiogenesis share common genes and pathways. Can we use these principles to 
develop new methods for stroke repair? 
2.  Be alert to new models of disease which may vertically integrate basic, clinical 
and epidemiological disciplines. For example, could advances in the understanding 
of infectious diseases or inflammation dramatically change our thinking about stroke 
pathogenesis? 
 
3.  Develop efficient methods of scanning other areas of science to enhance the 
likelihood of generating new ideas/concepts as well as information likely to be of use in 
developing new targets, new technologies and better translational processes. 
 
How, when and by whom these goals should be achieved 
1. How:  In establishing the new systems described earlier, investigators will need to 
work in different ways.  For example, sabbaticals and exchange programs and 
publication in completely novel areas could improve the cross fertilization process.   
Mechanisms should be established that will encourage investigators by measuring the 
impact and novelty of their work, rather than the current trend based on a researcher’s 
number of publications and citations.  A broad platform of stroke education should 
provide the underpinnings for this change (see Education section) with a focus on 
national research institutions and perhaps, the establishment of similar global 
institutions to cross country/cultural boundaries. 
2. By whom:  Scientific leaders around the world (organizations, institutes and others) 
need to bring together these new and novel teams.  Industry (e.g., pharmaceuticals, 
biotechnology) should also be involved, with a clear interface with the academic, 
regulatory and government world. Government funding agencies should stimulate this 
new collaborative paradigm, by providing funding for think tanks which could be local, 
national and, even more importantly, global. 
II. Stroke Prevention: Broadening the Approach and Intensifying the Efforts 
 
Introduction  
 
     Major chronic diseases such as stroke, heart disease, cancer, Alzheimer disease 
(AD), and vascular cognitive impairment (VCI), may be linked by common risk factors 
and pathophysiologic mechanisms.  Few simple steps like eating a balanced diet, 
exercising, maintaining optimal body weight, avoiding smoking and limiting alcohol 
consumption  can reduce risk of stroke by up to 80%.21,22  The occurrence of shared risk 
factors and possible common pathophysiologic mechanisms (e.g., inflammation, 
endothelial dysfunction)23  provide a backdrop for the establishment of chronic disease 
prevention or health preservation networks.  
      We propose three steps to influence future stroke prevention. The approach includes 
novel means to enhance stroke prevention and integrate strategies from within and 
outside the medical field, with an emphasis on synergistic opportunities and 
collaborations. 
 
Step 1:  Establish a Global Chronic Disease Prevention Initiative which includes 
Stroke as a Major Focus among a Cluster of Conditions  
     The Chronic Disease Action Group has provided a call to action to encourage, 
support, and monitor activity on the implementation of evidence-based efforts to achieve 
global, regional, and national programs to prevent and control chronic diseases.24 This 
group emphasizes on control of 3 key modifiable lifestyle risks: unhealthy diet, physical 
inactivity, and tobacco habit.  Multisectorial policies as well as long-term, sustainable 
action plans are encouraged to empower individuals, families, and communities to affect 
health-conscious behavioral change.  The creation of the Global Noncommunicable 
Disease Network (NCDnet)25 also focuses to reduce risk, morbidity and mortality related 
to four risk factors (tobacco use, physical inactivity, unhealthy diets, and the harmful use 
of alcohol).  It is a global collaborative effort between World Health Organization (WHO), 
member states, international partners and other stakeholders for the prevention and 
control of noncommunicable diseases.  
Recommendations  
1. Develop a leadership group that will work with existing organizations to set and 
advocate a chronic disease prevention agenda with stroke as a major focus, and the 
establishment of formal strategies to reduce unhealthy lifestyle and other risk 
factors.   
2. Establish collaborations between and representation of major health organizations 
and/or advocacy groups (e.g., WHO, WFN( World Federation of Neurology), 
WSO(World Stroke Organization), WHF (World Heart Federation),  NIH(National 
Institutes of Health, US) and Fogarty International Center, CDC (Centers for Disease 
Control, US), AHA(American Heart Association), ESO(European Stroke 
Organization), Chronic Disease Action Group, health maintenance organizations, 
etc).  
3. Incorporate mechanisms for cost-effective research monitoring into the overall 
strategy   
4. Government and industry should be represented in these collaborations. 
 
Step 2:  Employ and Promote the Population Approach for Stroke Prevention 
Recommendations: Newer approaches in the US and some other regions may 
include:  
1. Generate a paradigm shift among medical insurance providers, government, and 
health professionals toward a major emphasis on adequate and effective preventive 
health care and education programs.    
2. Establish collaborations between the global chronic disease prevention group, local 
stroke health advocacy organizations, and governmental chronic disease prevention 
offices. 
3. Employ community health workers to provide a means to assist in providing access 
to health care, adherence to treatment regimens, and overall adoption of ideal 
cardiovascular health at the community level.  
4. Develop positive incentives for; 
a. physicians who successfully achieve lifestyle risk control in their patients 
(e.g., pay-for-performance) and  
b. Patients/workers who adhere to healthy lifestyle behaviors.  
5. Incorporate a broader use of global vascular risk screening tools.   
6. Secure funding for additional research to determine the benefits of healthy lifestyle 
behavior and the most effective ways to modify behavior  
7. Study, for future application, other strategies such as legislation for and education of 
the community about lowering salt in the diet and polypill strategies26 in conjunction 
with healthy lifestyle behavior.  
 
Step 3:  Develop Public Health Communication Strategies Utilizing Traditional and 
Novel (social media/marketing) Techniques 
The basic components of establishing a public health communication strategy include: 27 
a. Identification of the health problem and target audience.  
b. Determine if the communication should be part of the intervention and if so, 
strategies to best reach the audience.  
c. Development and testing of communication concepts, messages, and materials 
including culturally appropriate messages for selected populations.  
d. Implementation of a health communication program based on the pre-test 
results. 
e. Assessment of the effectiveness of the messages and modification of the 
program accordingly. Traditional public health communication channels have 
included public service announcements, commercials, and newspapers, each 
carrying advantages and disadvantages.   
 
Recommendations:  
1. An evidence-based communication approach is required and partnership with an 
organization with substantial experience in public health communication (e.g. WHO, 
WSO, AHA) is desirable.   
2. Consider establishing , a centralized website for chronic disease prevention inclusive 
of stroke prevention and social media/marketing including but not limited to Twitter, 
Facebook, MySpace, LinkedIn, YouTube, and blogs.  Because of the high penetration 
usage rates of the internet and cell phones, these communication vehicles should be 
considered for communicating messages and researched for cost-effectiveness.   
3. Overall, the concept of development of a central “power grid” for chronic disease 
prevention messaging could be accomplished.  Local experts should be consulted to 
help develop and tailor individual, smart communication systems by area. 
 
III. Acute Stroke Management: Applying and expanding what we know 
Introduction 
     The establishment of Stroke Units and Stroke Centres has been the most significant 
contribution to the field of acute stroke management. Stroke Units are an effective 
intervention for the vast majority of stroke victims.  Stroke Centres along with pre-
hospital system organisation, access to rehabilitation and secondary prevention improve 
the quality of stroke care. 
     Enormous lobbying to reach policy makers has been pivotal to all advances in the 
development of stroke care systems to date. Once “Stroke” has reached political 
awareness, smooth implementation of care systems follows. The activities may be at 
the state or provincial level or even at the national level of countries such as Russia, 
Brazil, Spain or the UK. The political will to improve stroke care will allow new activities 
in the field of stroke to be launched. Nation- or state-wide documentation, standards, 
and quality control instruments can be implemented, and more financial resources 
made available for the development of stroke management and prevention initiatives.  
     The role of physicians in initiating and guiding such developments is paramount.  
The achievements in the pre-hospital system in the United States and in the state wide 
stroke unit programs in Germany, Brazil, Spain and Russia were only possible with the 
enormous input of stroke physicians. Large scale application of the Scandinavian stroke 
unit model has increased access to thrombolytic therapy and reduced the case fatality 
rate leading to remarkable improvement in the quality of stroke care.28 This should 
continue to be a major source of strength and direction. 
     Stroke care is expensive. It has to be supported in a zero-sum game of allocation in 
the setting of overall shrinking budgets of general health care - an action that will be not 
be warmly welcomed by colleagues in other fields. A helpful and key, evidence-
supported message is that improvements in stroke care frequently brings net health 
expenditure savings to governments, by reducing rehabilitation, nursing home, and lost 
productivity costs. 
     Although capitalizing on existing therapies is well justified, flexibility has to be built 
into the system to facilitate the successful application of new diagnostic and therapeutic 
approaches. It should be possible to introduce new tools and technologies, revise 
protocols, and modify the composition of the stroke care team to fit the requirement of 
new developments in the field. By doing so, the stroke care system will remain flexible 
and will be amenable to incorporate advances that will continue to improve the care of 
the stroke patient.  
Steps for improving stroke care worldwide. 
Step 1: Establishment of Stroke Centers and Stroke Units to assist acute stroke 
patients as a priority 
     Stroke Center hospitals with organized Stroke Unit care have made the most 
significant contribution to current stroke management. Efforts should be made to 
establish hospitals with Stroke Unit care in locations accessible to all stroke patients to 
reduce the global burden of stroke. These specialized centers should be organized 
according to the local and regional needs and classified in different levels of complexity 
according to the available resources and treatments.29-31 The lowest tier stroke service 
can be built with low cost equipment primarily focusing on well-trained interdisciplinary 
teams. Stroke Centers should implement evidence based protocols, including 
thrombolytic therapy.32,33 
 
Recommendations:  
1. Choose hospitals in each city or region to be established as stroke centers with 
organized Emergency Department and Stroke Unit care in accordance with Local 
Health Authorities (Examples: Scandinavian countries, Spain, Germany, US, UK, 
Russia );  
2. Classify Stroke Centre choosing the model that best fits the region, state or country 
and create an official certification process (Examples US, Germany, Austria, European 
certification efforts by ESO);  
3. Provide training by specialized staff with standardized protocols;  
4. Implement thrombolytic therapy for acute ischemic stroke;  
5. Implement quality control instruments (database of all patients); 
6. Alternatively, in order to solve the problem of overcrowded emergency rooms, the 
lack of beds in intensive care unit and the lack of space to build acute stroke units, more 
general Vascular Units can be established that would include acute stroke management 
as has been done in Brazil. This is a specialized unit in the emergency room with 
trained team to assist acute vascular disorders including stroke, coronary syndromes, 
pulmonary embolism and aortic diseases.  
 
Step 2: Development of regional systems of emergency stroke care  
     Activating the prehospital emergency medical system using designated stroke 
centers leads to a shorter delay in arrival at the hospital and better initial management. 
The training of ambulance teams and dispatchers in prehospital recognition of stroke as 
an emergency34,35 and the recognition of stroke signs increases the number of patients 
arriving earlier at hospital (Example: Greater Los Angeles).36 Scientific Statements 
recommend the development of regional systems of stroke care in which ambulances 
bring acute stroke patients directly to stroke center hospitals to rapidly provide approved 
stroke therapies, improving the outcome of patients.37 
Recommendations: 
1. Training prehospital emergency medical systems teams to recognize stroke and to 
bring acute stroke patients directly to designated stroke centers;  
2. Develop regional networks of stroke care between prehospital emergency medical 
systems and stroke centers;  
3. Whenever possible, use the same telephone number region wide to activate the 
prehospital emergency medical system (e.g., the European 112-campaign, 911 in the 
United States) 
 
Step 3: Improving Stroke awareness 
       Lack of recognition of stroke signs or lack of sense of urgency to seek help by the 
population is a major barrier for adequate stroke treatment. Stroke awareness 
campaigns can increase symptom identification thus resulting in a decrease in the time 
from symptom onset to hospital arrival and increase in the number of patients that may 
receive appropriate interventions. 
 
Recommendations: 
1. Promote evidence-based media campaigns providing public information about acute 
stroke signs and the urgency to call prehospital emergency medical systems;  
2. As stroke often renders patients themselves unable to recognize or communicate 
their symptoms, public education campaigns should inform not only at-risk individuals, 
but also family, friends, and on scene witnesses to call the prehospital emergency 
medical system if they observe an individual having signs of a possible stroke. 
  
A few successful examples from different parts of the world and different medical 
systems are described in Appendix 1 to illustrate how acute stroke treatment can be 
made more widely available. 
 
IV. Brain Recovery and Rehabilitation: Harnessing the Regenerative Powers of 
the Brain and the Individual 
 
Introduction 
     After the acute period, a stroke will often affect a patient’s life for many years. During 
the early days to weeks following stroke, spontaneous repair events usually lead to 
some degree of behavioral recovery.  The neurobiology of these repair events suggests 
several therapeutic targets to promote further recovery. Traditional rehabilitation is one 
of the therapeutic tools to augment the post–stroke recovery process.  A wide range of 
repair-based therapies are also in development.38 
 
     Rehabilitation and repair is a relatively young and diverse field yet includes the first 
days of inpatient care, to ensuing care by rehabilitative specialists, to years of chronic 
care in a range of settings.  Current research topics span plasticity, normal learning, 
pharmacology, genetics, robotic engineering, occupational therapy, physical therapy, 
and speech therapy and growth in these areas will continue to improve rehabilitation.39 
 
     Four steps for stroke rehabilitation/recovery therapies are considered below.  The 
goal of rehabilitation/recovery stroke medicine is to have more patients achieving better 
recovery in the weeks following a stroke, and experiencing less disability during the 
years that follow. 
 
Step 1. Translate best neuroscience, including animal and human studies, into 
post-stroke recovery research and patient care. 
Key issues:  The neurobiology of spontaneous recovery and CNS repair40 suggests 
several potential therapeutic approaches that could improve patient outcome, but more 
research is needed.  Current treatment options are limited. Although traditional 
rehabilitation medicine helps patients, a better understanding of its scientific basis could 
further increase its impact.  Active research may also lead to design of new therapies 
that ultimately may win approval such as those using pharmacological, cell-based, 
electromagnetic, robotic, or neuroprosthetic approaches. 
 
Recommendations:  Increased basic and translational research is needed.  A deeper 
insight into the neurobiology of post-stroke recovery is required.  The means by which 
principles of normal learning and development can be applied to stroke recovery need 
to be better understood.41 Tools for measuring the biology of stroke recovery in humans 
are needed, from behavioral measures with defined psychometric properties to 
biomarkers such as for recording physiology of repair-related events.42 Results of such 
research should be regularly compiled in both clinical and basic science State of the Art 
for Stroke Recovery Status Reports. This broad area of research may be best 
addressed by developing a group of Stroke Recovery Research Centers. 
 
     Translational studies are needed to determine the effects that various 
rehabilitation/repair therapies have on recovery, both as isolated therapies as well as in 
various combinations. A number of combination approaches can be envisioned, for 
example, traditional rehabilitation paired with a CNS stimulant, brain stimulation paired 
with a robotic therapy (with a single computer driving both), an angiogenic growth factor 
followed by a synaptogenic growth factor, or exercise therapy paired with motor imagery 
therapy.  In this regard, traditional rehabilitation can be regarded as one tool—albeit a 
key one--in the therapeutic armamentarium for stroke recovery. As with any medical 
therapy, the optimal timing, intensity, duration, and content of therapy needs to be 
continually refined using the scientific sound approaches. Some of these issues need to 
be clarified for individual therapies before combining into combination therapies.   
Specific to stroke recovery are issues such as defining the degree of task specificity for 
post-stroke training. The impact of comorbidities, both pre-stroke and post-stroke, 
needs consideration with a focus on identification of possible modifiable and non-
modifiable comorbidities.  
 
Step 2. The practice of post-stroke rehabilitation needs to be standardized based 
on best evidence. 
Key issues: Substantial data exists on the practice of post-stroke rehabilitation.43 as 
parallel research continues to refine the approaches, there is a need to apply currently 
existing knowledge to optimize the patient outcome. Key issues include the 
organizational structure, timing, intensity, and task-specificity of post-stroke therapy.44 
Attention to community reintegration is also needed. 
 
Recommendations: Detailed, standardized post-stroke therapy protocols need to be 
developed, and their practice associated with proper training.  This should extend to 
transition to community and then to a multi-year chronic phase of rehabilitation.  
Monetary and payment incentives must be redefined to drive implementation of these 
protocols. The lessons from published studies and best practices must be 
operationalized.45 This can be partly achieved by improved benchmarking of processes, 
outcomes, and costs. 
     Medical school and post-graduate training should incorporate the protocols and best 
practices and should include suitable educational media and modules to support the 
implementation. Many of these solutions can be addressed by development of Stroke 
Recovery Research Centers. 
 
Step 3. Develop consensus on, then implementation of, standardized clinical and 
surrogate measurements. 
Key issues:  The best standardized measures of behavior and outcomes after stroke 
need to be defined and then placed into clinical practice while continuing to generate 
appropriate research. These need to be used across rehabilitation systems and regions. 
These should be measured and communicated in a consistent manner.  Standardized 
rater training needs to be developed for these measures. 
 
     Surrogate markers of treatment effect also are needed, including imaging 
(anatomical and functional), physiological, and biological (such as genetics). These 
might be used as predictive tools for outcome, and thus be of value for triage; as entry 
criteria in clinical trials of repair-related therapies; or in evaluating treatment outcomes 
to guide clinical decision making. 
 
     Achieving consensus on clinical measures and biomarkers in this context would be 
useful for clinical practice and also for developing clinical trials of therapies targeting 
stroke recovery. 
 
Recommendations:  Experts need to be gathered to discuss these issues and to 
propose unifying strategies to achieve rapid progress in the study of rehabilitation 
interventions. One possible mechanism would be an International Harmonization 
Conference, which would help achieve expert consensus on post-stroke behavioral and 
clinical measures as well as on surrogate markers, as has been done in other 
neurological conditions.  Development of Stroke Recovery Research Centers would be 
useful to achieve such consensus, for subsequent pilot testing of the recommendations, 
and for defining means for broader implementation. 
     Further research is needed to define the psychometric qualities and performance of 
proposed surrogate markers. 
 
Step 4. Target repair-related processes in clinical research to advance stroke 
recovery. 
Key issues:  Available research suggests many strong candidates for therapies that are 
likely to improve post-stroke recovery by targeting repair-related processes. However, 
clinical trials in this domain are few and often small in size.  A significant need exists to 
design and execute clinical trials focused on stroke rehabilitation and repair. 
 
     Stroke rehabilitation/repair clinical trials need to be hypothesis-driven, properly 
designed and appropriately powered with vertical integration of basic, clinical and 
epidemiological disciplines. The clinical trial structure should extend beyond mere 
hypothesis testing to discovery and exploration, the latter being much needed in this 
expanding field with immense potential to help numerous stroke patients. 
 
      Randomized clinical trials are the mainstay of examining candidate therapies.  
Additional research structures also might be used to further address these issues.  
Examples include innovative trial designs such as a cluster randomized design, as well 
as shared databases. 
 
     Note that the impact of such trials will be maximized if paralleled by studies of clinical 
effectiveness and pertinent health economics topics. 
 
 Recommendations:   A Neurorecovery Consortium needs to be created, consisting of 
academic (basic and clinical researchers, likely based at the Stroke Recovery Research 
Centers), industry, government research, clinicians, and payers, with the mission being 
to define priorities and future actions for stroke recovery trials. Specific Stroke 
Rehabilitation/Recovery Conferences should be supported to address shared issues 
related to stroke recovery and rehabilitation. 
 
     Centralized strategic plans for brain recovery science should be developed, akin to 
the England Stroke Research Centers. Clinical trial networks should be developed to 
accelerate completion of stroke recovery clinical trials, using cardiac disease or cancer 
cooperative groups as examples. 
 
 V. Into the 21st Century: The web, technology and communications: New tools for 
progress 
 
Introduction 
     Major reductions in the burden of stroke can be achieved by providing better public 
education.  In many parts of the world, access to reliable medical information and even 
electricity is limited. The electronic means to disseminate health information (e.g., 
healthier lifestyle, risk factors, stroke symptoms and emergency response) are available 
in industrialized countries, but less so in developing countries.  There is a wide disparity 
in global internet penetration46 according to geographic (Figure 1) and demographic 
characteristics with older individuals less likely to access electronic information. 
Adoption of universal technology standards and worldwide unrestricted access to data 
will in part define how these disparities can be addressed. In the developed world, with 
the advent of high-bandwidth wireless delivery systems, there will be few regions 
without internet access, provided that sufficient resources are invested. In those parts of 
the world where connectivity is more limited, different strategies for knowledge 
dissemination and behavior change will need to be adapted to the available 
communication means (e.g., mobile phones, print, radio, television, word of mouth).   
Step 1: Worldwide unrestricted access to information  
Education for the public and professionals: To reduce stroke risk, electronic media 
enabled tools can be used for self-assessment and motivation for self-management. 
These information portals can provide self-administered programs and/or interactions 
with professionals.  
Support groups: Lay organizations (e.g., church, community groups) are an underused 
resource that can provide insights into the types of support and problem-solving that are 
most needed by stroke survivors, including advice on financial resources, legal matters 
and social benefits. Resources should be devoted to supporting these peer-to-peer 
networks with interfaces to reliable sources of health information.  
Recommendations 
The Public: To be free of bias, health information should be reviewed or provided by 
experts in stroke, in collaboration with experts in public education, without conflict of 
interest (e.g., government and non-government stroke-oriented health organizations) 
and delivered in a persuasive and understandable format consistent with principles of 
marketing and behavioral sciences as appropriate for the region.   
Professionals: Special task forces of these same organizations should prepare 
evidence-based online education for general practitioners, specialists, nurses, 
therapists and other healthcare workers in multiple languages, tailored to professional 
groups working in diverse surroundings. These electronic information clearinghouses 
should be accessible to health professionals worldwide and include interactive 
educational methods whenever possible. These materials should be adaptable to 
environments where access to electricity and electronic communications is limited. This 
material should also be available as a degree based distance learning program for 
healthcare workers worldwide. 
 
Citizens against stroke: Communication resources and social networking tools should 
be tailored to support local stroke initiatives consisting of professionals, decision 
makers, politicians, administrators, representatives of local industry and businesses 
together with lay people.  All initiatives should be tailored to raise public awareness of 
stroke and to spread information on its prevention and management.  
Step 2.  Better access to organized care for all stroke patients  
Diagnostics, acute care and rehabilitation: Evidence exists that advanced 
telemedicine communication technology for stroke (“telestroke”) is beneficial where 
immediate access to stroke expertise is not available.47-50 Telemedicine may help to 
provide stroke prevention, acute care and rehabilitation services in remote regions51 and 
smaller urban hospitals without stroke expertise and to extend clinical research into a 
broader global community. In addition, more innovative rehabilitation therapies, which 
can be administered in areas and countries with limited resources, must be 
implemented to reduce inequalities of access to rehabilitation. Close collaboration of 
health care administrators, physicians, allied health care providers, basic scientists, and 
engineers is needed to develop and implement new rehabilitation paradigms.  
Connecting professionals and patients: Electronic communications between patients 
and professionals have an enormous potential to enhance self-management of risk 
factors and promote healthier lifestyles (e.g., obtaining advice on medication use and 
adherence, prevention, follow-up lab test results and medical problems through a virtual 
healthcare visit or an e-consultation (https://www.mayoclinic.org).  Data management 
systems need to be developed to maximize the potential benefits of this emerging area 
and create manageable tools and actionable tasks for healthcare workers.  
Recommendations 
     Leaders and key stakeholders (including patients) will need to embrace these new 
models of telemedicine and virtual patient-provider interactions which will permit access 
especially for patients who are disabled or live in geographically remote regions.  A first 
step is to reduce barriers to telemedicine-enabled practice to encourage broader access 
to high quality stroke care and rapid treatment for acute stroke therapies. Development 
of novel technology-assisted rehabilitation methods should be encouraged.  
Step 3. Build centralized electronic archives and registries 
     Electronic health records (EHR) are critical for quick and reliable access to patient 
information, for effective communication of care plans between different providers and 
settings, and for reducing medical errors.  Furthermore, providing citizens with the 
option of having access to their own personal health records may enhance their 
adherence to treatment recommendations. 
     Electronic registries can help evaluate documentation of treatment practices, 
treatment efficacy and comparative effectiveness, and improve clinical management of 
stroke patients.  Registries such as SITS (Safe Implementation of Thrombolysis in 
Stroke- http://www.acutestroke.org/), and those of Austria, Finland, Scotland, Sweden, UK, 
Japan, and national quality improvement programs in the USA 
(http://www.strokeassociation.org/presenter.jhtml?identifier=3002728) have improved stroke 
care by providing feedback, benchmarks and sharing of best practices. Electronic 
resources should be developed to support the capture and analysis of patient reported 
outcomes for clinical care and research. 
Recommendations 
     All nations should pursue to develop national, interoperable EHR systems with the 
goal of supporting continuity of care through delivery of comprehensive medical 
information on demand at the point of care for all their citizens. Common data elements 
pertinent to stroke-relevant risk factors, treatments and functional outcomes should be 
included in the EHR systems. Ideally, nations should collaborate to develop 
international standards for data format and description to support international 
integration.  
Registries and evaluation of efficacy: All nations should participate in national or 
international stroke quality improvement programs or registries, or develop their own 
programs if current models are not suitable for their population or environment, in order 
to provide the highest quality stroke care.  
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VI. Fostering Cooperation among Stakeholders to Enhance Stroke Care 
    Introduction   
     Interactions among major stakeholders in the stroke field such as large stroke 
organizations, government agencies, non-governmental organizations (NGOs), industry 
and patient organizations can be mutually beneficial. Integrated activities between these 
groups can enhance patient care, the development and implementation of new 
therapies and the dissemination of new and existing information.  The following sections 
describe the activities/contributions of these five sectors and also provide three concrete 
suggestions of how to enhance mutually beneficial activities over the next several years.   
Large stroke organizations (LSOs) and Non-Government Organizations (NGOs) 
     Stroke is a prototype disease for coordinated actions, vertically (with other medical 
disciplines) as well as horizontally by interactions among stakeholder organizations, 
government and industry.  LSOs such as the World Stroke Organization (WSO) serve 
as a key component in these networks, providing important leadership roles in 
coordinating activities and in establishing stroke firmly on the global health agenda. 
Improved stroke management is crucially dependent on an effective organization in all 
aspects of care. The LSOs should establish clear policies, and provide 
recommendations through guidelines and other documents.  The LSOs also organize 
large scientific conferences providing a platform for scientific advances and interactions. 
Tackling the global burden of stroke constitutes a major health challenge.  
     The American Heart Association’s (AHA) formation of the American Stroke 
Association (ASA) 10 years ago and its evolution to date is an excellent example of how 
an NGO, in this case a voluntary health organization, can influence scientific discovery 
and the translation of science into guidelines, and how it can then implement programs 
to support guideline adherence, to improve outcomes, to provide extensive provider and 
patient resources and to advocate for system change.  AHA/ASA’s expertise as a 
convener of experts to develop consensus statements and guidelines, as a generator of 
patient and public education and its field structure of staff and volunteers who 
implement its programs all contribute to its success. 
     Going forward organizations such as AHA/ASA and WSO will need to collaborate 
extensively with other LSOs and NGOs, government agencies, industry and academia 
to further advancements in patient care and development of new therapies and 
approaches.  
Government 
The National Institute of Neurological Disorders and Stroke (NINDS) is committed to the 
development of better therapies to prevent stroke and to improve the outcome for stroke 
victims.  The NINDS Stroke Program Review Group52 outlined the priority areas for 
research and NINDS looks forward to an exciting new era in stroke research.  NINDS 
has a number of ongoing clinical trials that are evaluating novel prevention approaches, 
acute interventions and recovery enhancing strategies.  In addition to drugs and 
devices, the science of behavioral change needs to target the promotion of healthy 
behaviors decades before the age-dependent risk of stroke starts its exponential 
ascent.  The NINDS translational program works with and funds investigators and their 
industry partners to bring promising stroke therapies through pre-clinical development.  
The NINDS, however, faces a plethora of hurdles.  Unfortunately a number of important 
and expensive clinical stroke trials cannot be completed due to poor enrollment.  A 
greater emphasis on phase II studies should be considered to ensure that experimental 
therapies tested in rigorously conducted animal studies actually engage the intended 
biological target in patients.  
Patient Organizations  
     Patient organizations range from small, informal, local support groups to large 
corporations with significant influence. Interactions between patient organizations and 
other organizations flow both ways. The purposes of these interactions are many and 
therefore this topic is quite complex. The triggers for interactions are generally of three 
types: (1) issues of clinical service and patient safety; (2) driving innovation and 
science; and (3) influencing business and healthcare economics.  Patient organizations 
can be conduits for patients to influence healthcare organizations, government, industry 
and academia. Processes may be ad hoc or organized. Actions may be taken 
proactively or reactively. Patient organizations can be vehicles for patients to be 
influenced by healthcare organizations, government, industry and academia. Again, 
processes may be ad hoc or organized, and actions may be taken proactively or 
reactively.  
Industry 
     Industry plays a vital role in the development and implementation of novel therapies 
directed at improving the prevention and treatment of stroke.  Most new drug or device 
therapies are discovered by relevant companies or in-licensed from other sources.  The 
company then performs the necessary preclinical steps to allow for the performance of 
clinical trials. Clinical trials performed by the company that demonstrate safety and 
efficacy of the new therapeutic agent can lead to regulatory approval, presuming an 
adequate data package.  Industry thus provides a key link for stroke patient care, new 
and presumably improved therapeutic agents. Additionally, industry is an important 
source for the dissemination of new information about stroke to both physicians and the 
lay public. This task is performed by sponsorship of conferences, education seminars 
and small group meetings for both professional and lay audiences. The content of these 
educational endeavors should be free of bias, providing balanced and educationally 
sound information for the intended audience. 
Recommendations: 
Three specific recommendations to enhance cooperation among LSO’s, NGO’s, 
government, patient organizations and industry are:  
1. Provide an appropriate mechanism for the various stakeholders to communicate 
with each other about their needs and goals. 
2. Enhance clinical research by having these entities provide input about unmet 
needs and how to develop and disseminate new therapies. 
3. Enhance patient and physician education by jointly developing and implementing 
educational initiatives. 
 
     A method to achieve these recommendations and those of all aspects of this 
document is to establish a consensus working group of these stakeholders under the 
aegis of organizations such as the WSO/WFN to discuss develop and propose an 
overall agenda for stroke worldwide.   
 
VII. Educating and Energizing Professionals, Patients, the Public and Policy 
Makers 
Part 1: Educating and energizing professionals and patients 
Introduction 
     Detailed clinical stroke knowledge is increasingly important in Europe, North America 
and other developed regions and subspecialty training focused on stroke prevention, 
acute care and rehabilitation has been formalized.32,53 Stroke units have become 
common in developed countries.  In poorer countries, especially in those classified as 
“low-income” by the World Bank, specialized care hardly exists.54 A first step in 
improving stroke care globally is to improve the stroke-related education of care 
providers in developing countries. There are mechanisms in place for distributing 
knowledge and education related to HIV/AIDS, malaria and other infectious diseases. 
These same models could be applied to stroke education. 
     Several organizations including the American Stroke Association (ASA), the 
European Stroke Organization (ESO) and the World Stroke Organization (WSO) have 
educational and professional training websites.  For example, the WSO site is the World 
Stroke Academy (http://www.world-stroke-academy.org/). It is available globally and is free.  
It is endorsed and supported by other educational initiatives including those from the 
ASA and the ESO.  Other programs such as those from the American Heart 
Association/ASA (http://my.americanheart.org/professional/) and the ESO (http://www.stroke-
university.com/) provide professional educational resources. Globally, there are 
insufficient numbers of physicians trained in stroke.  NET SMART (Neurovascular 
Education and Training in Stroke Management and Acute Reperfusion Therapy) is a 
government funded, evidence based, on-line educational system (http://www.netsmart-
stroke.com/) offering programs to support the learning needs of advanced practice nurses 
(nurse practitioners and clinical nurse specialists). Stroke educated nurses, more 
numerous than physicians, are capable of playing instrumental roles within telestroke 
networks.55 In Europe, a downloadable eCME certificate can be obtained that is 
recognized by other programs such as the European Masters in Stroke Medicine 
(http://www.donau-uni.ac.at/en/studium/strokemedicine/index.php)  
     The WSO’s ‘ABC of Stroke Management’ program is directed to health care 
providers in developing countries. It is being used in China, South Africa and Vietnam, 
and is an effective tool for postgraduate medical training. 56,57 In Vietnam, 6,000 medical 
doctors have finished WSO-sponsored stroke training. Approaches for rapid and 
accurate diagnosis and the importance of prevention of complications are 
emphasized.58 Improving the availability of effective medications throughout the world is 
critical. The use of telemedicine to extend stroke expertise to underserved areas may 
be possible.48 The wider use of early mobilization and task-dependent rehabilitation to 
optimize long-term outcomes, including reintegration of stroke patients into the family, 
work place and community is an important goal.  It is important to develop a concept of 
‘Brain Health’ that can be promoted for primordial and secondary prevention.  
     Patient and bystander responses to stroke symptoms are often delayed.59 Patient-
focused voluntary organizations have developed programs to increase the stroke 
knowledge of the general public, stroke patients, and their families. The AHA/ASA along 
with the American Academy of Neurology and the American College of Emergency 
Physicians (Give-Me-5), the ESO, and the Stroke Alliance for Europe (SAFE) have 
developed informational brochures and advertisements for this purpose.  It is important 
to further disseminate these materials as teaching aids in schools and communities. 
Recommendations:  
Step 1:  Increase education directed at professionals including health care 
providers on a global scale by using on-site and website stroke teaching programs that 
are integrated into the medical education curricula. Recommendations should be based 
on a ‘Brain Health’ concept that enables promotion of preventive measures.  The aim is 
to make professional specialized care available to stroke patients throughout the world 
within the next decade. 
Step 2:  Further develop national health education programs offered for stroke 
survivors and their families. These programs should be offered in schools and 
communities under the leadership of the scientific organizations such as the WSO, the 
AHA/ASA, the ESO and other regional organizations. The aim is to improve stroke 
prevention and the public’s recognition and response to stroke symptoms. 
Part 2: Educating and energizing the public and policy makers 
Introduction 
     World-wide efforts to increase knowledge and concern about stroke, its prevention, 
treatment opportunities, and outcomes have also focused on politicians and key opinion 
leaders. The role of governmental policy on stroke research and care is increasingly 
recognized.  
     In the US, advocacy efforts have largely been directed at increasing or at least 
sustaining funding for research supported by the National Institutes of Health(NIH).60 
Advocacy, in part, led to NIH Progress Review Groups aimed at identifying targets and 
strategies for stroke-related research. In addition, national advocacy efforts have 
supported cardiovascular and stroke prevention activities of Centers for Disease Control 
and Prevention. Specific targets included support of FDA oversight of tobacco products.  
Within states, advocacy has been aimed at improving the organization of the delivery of 
stroke-related health care.31 Individual states have established Stroke Task Forces or 
legislative committees focused on stroke care issues, such as assessments by 
emergency responders, transport of stroke patients to the nearest appropriate hospital, 
identification of primary stroke centers and acute stroke treatment capable hospitals, 
and the use of telemedicine. Legislation to prevent cigarette smoking in indoor public 
spaces has been enacted in several states. 
     Educating the public about stroke risk factors, prevention and response has been 
challenging. Public knowledge about stroke in the US continues to be poor, particularly 
in minority communities.61,62 Recently, the ASA, American College of Emergency 
Physicians, and American Academy of Neurology began a uniform education campaign-
“Give Me 5”- aimed at improving recognition of stroke symptoms.  The ASA Power to 
End Stroke program focuses on African-Americans, who have approximately twice the 
risk compared to Caucasian Americans. “You’re the Cure” is the AHA/ASA grassroots 
advocacy network. Through “You’re the Cure,” thousands of advocates can be 
mobilized to support specific pieces of legislation or programs affecting stroke through 
targeted e-mails, phone calls and letters to relevant policy-makers.  Although a great 
deal has been accomplished, much remains to be done. 
     The European Parliament founded the Stroke Alliance for Europe (SAFE) in 2004, 
and includes representatives from 17 countries.63  In Europe, policy makers have 
become engaged in the European Union by activities from the European Brain Council, 
the ESO jointly with the European Stroke Conference and the SAFE movement. Topics 
include the promotion of awareness of stroke-related health costs64 and the large 
discrepancies between eastern and western Europe including the much higher 
prevalence of risk factors and stroke in eastern countries.  
      European specialist groups have lobbied for increased funding from the European 
Science Foundation and led to a European Stroke Workshop in Brussels, hosted by the 
European Commission. The resulting European Stroke Network links stroke research 
from bench-to-beside.65 New initiatives (“Strike out Stroke” 2009) address the general 
public as well as members of the European Parliament focusing on problems related to 
the use of anticoagulants for stroke patients.  
Recommendations: 
Step 3: Increase funding for public education and research supported by regional 
and national agencies. Continue support for advocacy aimed at improving the 
organization of the delivery of stroke-related health care based on evidence-based 
recommendations addressing gaps in the care-delivery system.  
Step 4: Educate and inform the general public about stroke risk factors, 
prevention and response. Use best practices such as “Give Me 5”- aimed at improving 
recognition of stroke symptoms, the ASA’s "You’re the Cure" advocacy program and the 
‘Strike out Stroke’ campaign in Europe. 
 SUMMARY 
     To accelerate progress in stroke, we need to reach beyond it; scientifically, 
conceptually and pragmatically. 
     Scientifically the solutions lie beyond our limited models. All the major neurological 
brain diseases share common mechanisms such as inflammation, apoptosis, 
mitochondrial damage, oxidative stress, excitotoxcitity and neurotransmitter failure.66 By 
and large these mechanisms are studied in relation to individual diseases, not from a 
biological, evolutionary and integrated viewpoint. A close study of the development of 
the nervous system may hold many clues as to how the brain repairs itself.  Moreover, 
development and aging may to some extent be mirror images of each other. Stroke in 
the neonatal brain67, children and women68,69 have special features that need to be 
understood and addressed. 
     Our focus has been on lesions in the brain. Aging and the complex interaction of 
genetics, epigenetics and environment and the occurrence of concomitant pathology 
render individuals’ brains unique. For example, cerebral infarcts tend to shrink and the 
inflammation subside with time.  The opposite occurs experimentally in the presence of 
amyloid.70Given that several common neurological conditions share the same 
mechanisms, a systematic approach may produce therapeutic targets that would be of 
benefit to more than one disease.  It matters not only what lesion, but whose brain. 
     Conceptually we need to think not only of dramatic strokes of sudden onset, 
sometimes heralded by sudden losses of speech, sight, movement or feeling, but of 
subclinical strokes, the most prevalent type of cerebrovascular disease identifiable by 
subtle cognitive dysfunction usually a change in executive function.12  Moreover, in the 
elderly brain amyloid deposition and Alzheimer lesions may co-exist, and at times 
interact with the vascular lesions. 
     Pragmatically we need to realize that if we are to become more effective in the 
diagnosis, treatment, rehabilitation and prevention of stroke we have to reach beyond 
our hospitals and clinics into the community, other disciplines and the public and a 
larger part of the world.  
     We need to survey, systematize and synergize what we do. We need to survey 
broadly, systematically and specifically what we know of basic brain mechanisms of 
disease. We need to become aware of other models, such as infectious diseases, which 
often has an integrated, epidemiological, clinical and basic science approach. 
     In terms of acute care and rehabilitation, an organized approach seems to have 
been the key to the many advances. Although countries like Spain have a national 
stroke strategy and effective regional programs such as those of Catalonia71 and 
Madrid72, the majority of the countries do not. Stroke unit care should be considered a 
treatment/intervention in itself similar to any pharmacological treatment or a surgical 
procedure. There may well be other models, such as trauma, that may provide useful 
parallels and lessons.  
     Systematization and evaluation has been a key in many of the advances that have 
occurred in stroke in the past four decades.  A prototype has been the randomized 
clinical trial, in which a hypothesis is tested according to prospectively agreed protocols, 
the collection of the data monitored and the results evaluated.  Randomized clinical 
trials are but one example of the more generic principles.  
     We need to reach beyond North America, Western Europe and Japan, where most 
clinical trials have been performed.  Other parts of the world are creating infrastructures 
that make them capable of participating in clinical trials and other studies that can 
accelerate finding the answers too many common problems.  The EC/IC Bypass 
Study73 was an early example of how an international randomized clinical trial could 
reach an answer much more quickly than if it had been done in one country alone.  
More recently we saw the example of the first proof of tPA effectiveness in stroke being 
demonstrated in an American Study4 while the extension of the time window was 
recently shown by a European Study.74 
     We need to become imaginative in designing multiple types of clinical trials, from 
active registries to simple and more complex randomized clinical trials.  The idea would 
be that everything that is done in relation to stroke becomes part of some evaluation. An 
important aspect of any evaluation is standardization, with a need to make minimum 
common definitions of important items in a protocol, so that databases can be made 
compatible and larger volumes of information can become available for analysis, model 
building and testing. 
     At the moment, we have a glut of guidelines, but not enough guidance or guides.75 
Most guidelines are developed on the basis of the level of evidence, but little attention is 
devoted to the relative impact of specific items.  Not all are of equal value.76 We need to 
evaluate and rank the relative value of each activity in terms of return per unit 
investment of time, resources or both.77 The comparative effectiveness research thus 
generated would improve clinical decision making and lead to better allocation of scarce 
medical resources. 
     Stroke is no longer a disease of affluence. About 87% of the 5.7 million deaths 
annually attributable to stroke occur in low-income and middle-income countries.78 The 
risk factors like hypertension, diabetes and obesity are assuming epidemic proportions. 
Some 285 million people worldwide will live with diabetes in 2010, 70% of which will live 
in developing countries.79 Moreover, by 2050, the population aged 60 or over is 
expected almost to triple, increasing to 1.6 billion in the developing countries.80 
 
      The Institute of Medicine’s recent report recommends building evidence-based, 
locally relevant solutions by improving global collaboration among stakeholders to 
promote cardiovascular health in the developing world.81 Aligning chronic disease 
priorities with other health and development priorities has the potential to synergistically 
improve economic and health status. 
     There is much value in doing the simple things right in terms of prevention. “Death in 
old age is inevitable, but most deaths before old age are avoidable”.82  Hypertension is 
the single most powerful and prevalent risk factor for ischemic and hemorrhagic stroke 
and vascular cognitive impairment and yet too often it remains unrecognized or 
untreated. Blood pressure control has the greatest potential for stroke prevention.  
 
     The concept of “Vascular Health” or “Brain Health” needs to be promoted. As 
atherosclerosis starts early in life, the preventive efforts should target children, youth 
and mothers.  Everyone needs to be involved at all stages of prevention with an 
emphasis on healthy living and creating an environment that nurtures it.  
     Finally, we need to synergize with vertical integration of basic sciences, clinical 
sciences and population approaches. The digital age provides wonderful opportunities 
for integrating and evaluating all aspects of our activities. 
 
Next Steps  
The immediate need is to pursue specific recommendations: 
1. A systematic review of all that is known of basic brain mechanisms of injury 
and repair along the life cycle. This can be accomplished at several levels 
a. Review of the existing literature 
b. Making it a topic of ongoing scientific conferences, such as the Princeton 
Conference or that of priority setting exercise of funding agencies.52 
c. Organize a highly interactive synergium with a participation of scientists, 
clinicians, pharmaceutical companies, and health regulators.  The 
synergium should be broad enough that each mechanism can be 
examined in the light of several diseases. 
 
2. To organize a working group that will recommend a minimum set of data 
points to be collected on all stroke or potential stroke patients.  This already 
has been done for capturing vascular cognitive impairment from the 
epidemiological, clinical, neuropsychological, imaging and experimental 
viewpoint.83 It may be that it simply needs modification or adaptation. 
 
3. Another working group could evaluate the relative advantages and 
disadvantages of different clinical trials including novel approaches to use 
registries to evaluate different diagnoses and treatments. 
 
4. The World Stroke Organization already has a working group on guidelines 
that could be enlarged and asked to prioritize them with a simple method of 
evaluating their impact. 
 
5. A working group on surveying and evaluating stroke education, with   
methods of integrating and credentialing those who engage in stroke work. 
 
6. Develop nodular models of comprehensive stroke care, rehabilitation and 
prevention on the principle that some components are essential, but that they 
need to be adapted in the community where they are to be implemented. 
Professional education including a more comprehensive education on stroke 
and stroke recovery for medical school curricula as well as residency and 
fellowship training. The latter may be best done at Centers of Stroke 
Emphasis or Stroke Recovery Research Centers. 
 
7. Support the efforts of Raad Shakir, Secretary General of the World 
Federation of Neurology and Chair of the Expert Committee advising on 
Diseases of the Nervous System for the International Classification of 
Diseases84 (ICD-11) and Bo Norrving, President of the World Stroke 
Organization to reclassify stroke from a cardiovascular to a disease of the 
nervous system and vascular dementia from mental diseases to brain 
diseases. 
 
8. Precompetitive Stroke Recovery Initiative (SRI): We ought to consider pre-
competitive consortia for stroke recovery that is similar to that currently in 
operation for AD-the Alzheimer's disease Neuroimaging Initiative (ADNI)85. 
Perhaps collectively (academia ,industry and government), we could create a 
"SRNI" (stroke recovery neuroimaging initiative) - a precompetitive consortia 
to enroll and carefully study patients for the natural history of stroke recovery- 
imaging, scales and biologic samples. The groups involved would agree to 
what endpoints should be studied. This would help not only in understanding 
the pathophysiology of stroke, but also in the design of clinical trials to ensure 
that the proper endpoints are used and that they are powered appropriately.  
9. Educate and energize professionals, patients, the public and policy makers by 
using a ‘Brain Health’ concept that enables promotion of preventive 
measures.  
10. Organize a working group that will oversee the above and other initiatives that 
may arise from the recommendations of the Synergium. 
 
CONCLUSION 
We have come a long way, but we have even further to go. The progressive 
transformation of our field in the past 40 years, the accelerated pace of science and the 
growing need for our contributions, will assure that the next 4 decades will prove even 
more fruitful than the last. 
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Appendix  
 
In the following section, a few successful scenarios from different parts of the world and 
different medical systems are described to illustrate what can be done to make acute 
stroke treatment more widely available depending on the local conditions. 
I. The state wide program of stroke unit care and implementation of thrombolysis in 
the German State of Baden-Württemberg, in which the Ministry of Health, 
together with stroke physicians, has embarked on a state wide program to 
improve stroke management, is described. 
II. The strategies for improvement of pre-hospital management of stroke patients in 
the United States is described, a process which was primarily triggered by stroke 
physicians.   
III. The government led nationwide system of medical emergencies including stroke 
which has been started in Brazil is reviewed.  
IV. The current attempts being undertaken in the United Kingdom in organizing 
stroke centre care in the metropolitan areas are also reviewed. 
V. The example of South Africa is presented which shows how stroke medicine can 
be brought into rural areas with the help of metropolitan stroke centres, which 
themselves are not similar to centres found in Western Europe or North America.  
VI. The current efforts being undertaken in the Russian Federation to improve stroke 
care are also described. 
 
 
1. The Stroke Unit System in Baden-Württemberg, Germany 
 
About 10 years ago, the first stroke units were established in the State of Baden-
Württemberg. Once the idea of creating stroke units in this state came up, the state 
government together with an action group of stroke physicians created a master plan. A 
program, in which 7 comprehensive stroke centres, all with ICUs, neurosurgery and 
interventional neuroradiology were initiated. In addition, 12 regional stroke units in close 
cooperation with some of the comprehensive stroke centres were established. Finally, 
another 25 local stroke units serving rural areas, smaller cities and remote districts were 
introduced, for which a close connection with either regional stroke units or stroke 
centres was required. The creation of this 3 level stroke unit system was very 
successful and the certification of the stroke units was in the hands of the stroke 
physicians with official recognition by the government. There is a state-wide compulsory 
documentation for all hospitals, who receive stroke patients although they do not have a 
certified stroke unit.  
The yearly reports are extremely helpful and eye-opening. The incidence of strokes in 
the state is much higher than was initially believed. In 2008, more than 36,000 stroke 
patients have been treated in hospitals of the State of Baden-Württemberg, which 
translates into an incidence of 360 for 100,000 residents per year. The report also 
shows that more than 70% of all patients in the state are now being treated in certified 
stroke units or in intensive care units with only 30% of patient remaining in non 
specialized wards.  
Interestingly the state-wide utilisation of rtPA is almost 6% with up to 20% in some of 
the comprehensive stroke centres. ICU treatment for stroke is available for about 12 to 
15 % of the stroke patients, specifically for SAH, ICH and severe ischemic stroke. ICU 
treatment takes place in hospitals with certified stroke service, mostly on neurologically 
run ICUs. In addition to the provision of acute care, stroke unit treatment, thrombolysis, 
and ICU care, there is also an improvement in the introduction of secondary prevention 
methods.  
 
2. The US Preclinical Services 
 
In the United States, throughout the past decade a remarkable transformation in the 
prehospital system of care has been under way that is expanding the access of stroke 
patients to proven stroke therapies.  The general framework for this evolution has been 
the policy and scientific statements of the American Heart Association/American Stroke 
Association and the Brain Attack Coalition1,2 that recommend the development of 
regional systems of stroke care in which ambulances bring acute stroke patients directly 
to hospitals certified to rapidly and reliably provide approved stroke therapies. Three 
types of stroke-receiving facilities are recognized:  
1. Primary Stroke Centers that are able to provide organized inpatient stroke pathway 
care and intravenous fibrinolysis,  
2. Comprehensive Stroke Centers (CSCs) that provide endovascular, neurosurgical, 
neurointensive care and other advanced treatments, and  
3. Stroke Support Hospitals (SSHs) that can provide initial interventions and then send 
patients to a definitive care center. These are often supported by telemedicine 
connections to a Primary Stroke Center. The system is made possible by widespread 
adoption in the US of training for ambulance dispatchers and paramedics in prehospital 
stroke recognition, using validated instruments like the Los Angeles Prehospital Stroke 
Screen (LAPSS)3 ,the Cincinnati Prehospital Stroke Scale (CPSS)4 and the Expanded 
LAPSS (also known as MASS)5 and by growing dissemination of stroke telemedicine 
(telestroke) systems6,7.  
In the US, prehospital emergency medical systems are regulated primarily at the state 
and county level. Hence progress has occurred in saltatory fashion as more and more 
state and county systems adopt the regionalized stroke care system model. Initial 
efforts have focused most intensively on implementing Primary Stroke Center systems, 
with less widespread, but still growing, use of CSCs and SSHs. As the first decade of 
the 21st century closes, at the end of 2009, 13 states and additional large counties have 
in place regional systems of stroke care in which stroke patients are brought directly to 
over 850 PSCs certified by either the Joint Commission on Hospital Accreditation or by 
state public health agencies. The initial adopters have tended to be larger states and 
counties, so that currently approximately 51% of all Americans, 154 million people, live 
in a jurisdiction in which, when they activate the 9-1-1 emergency response system, 
they will be brought to a hospital certified to be able to provide rapid and effective basic 
acute stroke care. Efforts continue to further expand the system to smaller and rural 
areas, with the long-term goal of assuring all acute stroke patients access to proven 
therapies. 
 
3. The Brazilian Program 
 
Brazil is a country of 190 million inhabitants with enormous social, cultural and 
economic differences. The population receives public medical assistance paid by the 
Federal Government and only 20% of patients have private health insurance. Stroke is 
the first cause of death killing 90,000 Brazilians every year. In June 2008 the 
Coordination of Urgency and Emergency of the Ministry of Health started a Stroke 
Project built by the vascular neurologists. The Brazilian Stroke Network was founded to 
enable hospitals to treat acute stroke, train the emergency and stroke team, and 
organize local networks with the National pre-hospital medical systems (SAMU - 
Serviço de Atendimento Móvel de Urgência). Four levels of stroke hospitals were 
defined:  
Level A: a comprehensive stroke centre,  
Level B: a hospital with neurologist and CT scan available 24 hours a day but without 
MRI or endovascular intervention,  
Level C:  a remote centre for thrombolysis with telemedicine connected to a Level A 
Centre (for areas without neurologist)  
and Level D: a hospital without structure for thrombolysis 
All stroke patients that receive thrombolysis are being included in the SITS Registry. In 
overcrowded emergencies rooms Vascular Units (VU) have been defined as a 
geographic area with monitored beds for all kinds of acute vascular diseases such as 
stroke, myocardial infarction, aortic diseases and pulmonary embolism. The VU 
combines the benefits of Acute Stroke Units and Chest Pain Units and has a trained 
emergency team to start the protocol with the support of neurologists 24 hours a day for 
stroke treatment. 
In each State the program was tailored according to the local conditions (infrastructure 
and technical staff) and was developed together with Local Health Authorities. Each 
hospital was visited, classified and certified by stroke neurologists.  
The Pilot Project was developed in Porto Alegre, South of Brazil. Within 1 year, 4 Stroke 
Centers were started and an increase in the number of thrombolysed patients was 
seen. The program will be expanded to 15 of the 26 States.  
 
 
4. Stroke Care in South Africa 
 
In 2007, the South African Stroke Foundation amalgamated with the South African 
Heart Foundation to form the South African Heart and Stroke Foundation. The objective 
of this organization is to improve public awareness of cardiovascular disease through 
the media by providing information on all aspects of stroke (symptoms, risk factors, 
prevention, treatment, rehabilitation and coping strategies etc).  
Although national guidelines recommend that the stroke unit model of care be 
implemented in the health care system it is acknowledged that in South Africa the stroke 
unit model of care has not been widely implemented despite compelling evidence of 
efficacy including published data from a stroke unit in a small secondary level South 
African Hospital in Cape Town.8 
Many problems beset the implementation of current proposed guidelines for stroke care. 
Most hospitals have not developed protocols for stroke care and often there are no 
systems in place for patients after discharge. In certain provinces stroke is not 
considered a priority by the local health authority given the burden of the HIV epidemic. 
Shortages and pressure for hospital beds frequently result in stroke patients being 
discharged early.  
 
Currently there is only one comprehensive acute stroke unit in an academic tertiary 
hospital in the country [Groote Schuur Hospital (GSH), University of Cape Town]. A 
stroke training course (12 modules) was developed on site for nurses and allied 
professionals and has attracted staff from other local hospitals. This unit has assisted in 
the establishment of stroke services and units at other hospitals in both the public and 
private sector.  
 
Essential to achieving improved stroke care would be the development of a stroke 
training program that could be used for on-site in-service training in stroke care at all 
levels of the South African health care system in the different provinces. Following 
discussions with the Directorate of Chronic Diseases, National Department of Health, 
the University of Cape Town (UCT) Stroke Unit have engaged in an initiative to develop 
such a programme with the South African Department of Health. The objectives of this 
undertaking include: 
 1. Develop and expand the UCT/GSH course modules on Stroke Care in a format 
for use for in-service training at health care facilities nationally in both the public 
and private sector. 
2. To develop core competencies for stroke care 
3. The training program addresses principles of management that are in 
accordance with those in the national guidelines for stroke care.  
4. Program to be inclusive and representative of cultural and ethnic diversity of 
peoples of South Africa. Material from all provinces incorporated into the 
programme.  
5. The training program should be tailored to the resources (physical/and staff) 
available at all levels of in-patient health care (Level 1, 2, and 3 hospitals – with 
more advanced competencies required for level 2 and 3) 
6. Format of the program must be accessible and easy to use even in remote 
settings. 
7. Programme to enable capacity building amongst healthcare workers  
8. Develop criteria for accreditation of stroke training within our health care system.  
 
The overall objective of developing the UCT training course in stroke care suitable for 
in-service training on a national level would be to facilitate the implementation of the 
stroke unit model of care (as detailed in the new draft national guidelines) more widely 
within the health care system.  
The national Department of Health has recommended that the Western Cape Province 
would be ideal as a pilot site to both develop and evaluate such a programme. The 
Western Cape Health authority has approved the development of the first module of the 
course for evaluation and feedback. It is envisaged that such a training program would 
be of value not only in South Africa but also in other developing countries with similar 
resource constraints. 
 
 
5. Implementing Stroke Infrastructure in the UK  
 
Provision of acute stroke care is undergoing major change and improvement 
across the UK.  Improving stroke care is a major health care priority in England 
which has an underpinning English Stroke Strategy. In England a major media 
campaign using the FAST assessment has increased public awareness. All 
centers receiving acute stroke patients are now expected to be able to provide 
rapid admission to an acute stroke unit with multidisciplinary care and the 
expertise to deliver thrombolysis where indicated. This is leading to major service 
reconfiguration in some areas such as London where all acute stroke patients 
(11,000 per annum) will be directed to eight hyper-acute Stroke Units. 
 Ambulance services are now playing a key role in ensuring early accurate triage 
of patients to these units. Thrombolysis is now delivered to around 3% of UK 
stroke patients and the rate is increasingly rapidly. Access to imaging has 
improved substantially in recent years but only a few centers are currently able to 
offer a 24/7 interventional stroke neuroradiology service. 
  
In England and Scotland parallel stroke networks covering populations of around 
2 million have been created to improve clinical care.  The NIHR (National 
Institute for Health Research) Stroke Research Network provides research 
support through eight local research networks in England (3-6 million population) 
which work closely with the clinical networks. Similar networks have been 
established in Scotland, Wales and Northern Ireland. Over two thirds of UK 
stroke services are now involved in clinical research. Participation in acute stroke 
research correlates with improved standards of acute stroke care.  National audit 
programs conducted annually have facilitated improvements in care across the 
UK. 
 
6. The Russian Federation Approach 
 
In 2006, the Public Health Ministry of the Russian Federation together with National 
Stroke Association made a decision to create and introduce the “State Government 
Program of Development of Stroke Care System in the Russian Federation”. This 
program was created in 2007 and included three main components:  
1. Developing a primary stroke prevention strategy according to the population-based 
risk profile,  
2. Creating the Stroke Unit System in all regions of the country (for the 142 million 
Russian population), and  
3. Developing a quality control and management system mechanism.  
The network of primary stroke units (30 beds per 200 000 adult population) and 
comprehensive (regional) stroke centers are to be implemented in all regions of the 
Russian Federation based on two principles: access to transportation (30–40 minutes 
from call to door, including rural and remote regions) and adequate coverage of 
population (one SU for 200 000 population). Each primary stroke unit is to be equipped 
with an express-laboratory, CT-scanner, ultrasound, ICU, multidisciplinary rehabilitation 
facilities, and operating room facilities for emergency.  A program has been created, in 
which each region of Russia will have 1 to 3 comprehensive stroke centres (1 centre per 
1.2–2.0 million population). All of these will have not only basic facilities, but also 
vascular neurosurgery, interventional neuroradiology, and a telemedicine consultative 
centre. Each comprehensive stroke centre will be connected with a network of 3 to 6 
primary SUs with telemedicine, and perform the function of coordinating activities of all 
attached primary SUs, providing them with clinical and radiological support. All primary 
SUs and comprehensive stroke centres work according to common National Stroke 
Standards and are enrolled on the common computerized “National Stroke Registry” 
program with a system of quality control and quality management of stroke care (by 
means of tariff setting rules with adequate penalties and incentives). In order to train 
staff, special educational programs were developed (for multidisciplinary teams and all 
necessary specialists). More than 1500 specialists are training on these courses 
annually.    
The Program is financed from Federal budget and from budgets of constituent territories 
of the Russian Federation. In 2008 the Program was first started in 12 regions of the 
Russian Federation. Data collected over the 9 months of 2009 demonstrated its high 
efficiency. More than 90% of all stroke patients in these 12 regions are now being 
treated in SUs (instead of 30–40% in the previous year). Four hundred and sixty three 
patients received treatment with rtPA during this period. The percentage of patients 
independent in daily living at day 30 increased to 37%, and 30-day mortality rate 
decreased to 14.6%. Most significantly, stroke mortality in the whole Russian Federation 
decreased by 8.5% in that period compared to 2008. 
In 2009, the program was implemented in 12 more regions of the Russian Federation. 
In 2010 it will start in another 14 regions and by 2013 the new system of stroke care will 
be deployed in all 83 regions of the country.   
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